Table 1 General analyses of the high-throughput RNA-seq.
From: Characterization of cancer omics and drug perturbations in panels of lung cancer cells
Dataset | Cell line | Total data points* (% passed QC) | Average numbers per data point | ||
|---|---|---|---|---|---|
Mapped reads | %mapped | %intron in mapped | |||
Dataset-1 (4 conc. × 3 time points) | A549 | 249 (87%) | 1,455,347 | 68% | 8% |
H1299 | 253 (89%) | 1,275,695 | 69% | 7% | |
H1648 | 251 (88%) | 1,319,718 | 68% | 7% | |
H2347 | 245 (86%) | 1,414,144 | 70% | 9% | |
II-18 | 231 (81%) | 1,433,442 | 72% | 10% | |
Dataset-2 (1 conc. × 1 time point) | 23 cells | 2011 (91%) | 1,295,897 | 72% | 9% |
